Therapy Shows Promise for Rare Leukemia in Children

Kinase inhibitor trametinib may spare patients from intensive treatments, such as stem cell transplant, for an aggressive form of blood cancer in small children.

Read more: https://www.aacr.org/patients-caregivers/progress-against-cancer/therapy-shows-promise-for-rare-leukemia-in-children/